2008 BIOCOM Executive Committee:

Chair:

Greg Lucier, Invitrogen Corp.

Vice Chair:

M. Wainwright Fishburn, Jr., Cooley Godward Kronish LLP

Chair Elect:

Randall E. Woods, Sequel Pharmaceuticals

Emeritus:

Paul Laikind, Ph.D., Metabasis Therapeutics, Inc.

Vice President and General Counsel:

Stephen Ferruolo, J.D., Ph.D., Goodwin Procter LLP

Vice President – Finance:

Theresa Drew, Deloitte

Vice President and Secretary:

Kennon W. Baldwin, Ferguson Pape Baldwin Architects

Vice President – Industry:

Dan Bradbury, Amylin Pharmaceuticals

President and CEO:

Joseph D. Panetta, BIOCOM

Life Director:

David Hale, Somaxon Pharmaceuticals

Life Director:

William Rastetter, Venrock Associates

Jack Lief, Arena Pharmaceuticals, Inc.
David Marino, Irving Hughes
Steven J. Mento, Ph.D., Conatus Pharmaceuticals, Inc.
Tina S. Nova, Ph.D., Genoptix, Inc.
Trindl Reeves, Barney & Barney
Larry Stambaugh, Apercu Consulting
Kleanthis G. Xanthopoulos, Ph.D., Regulus Therapeutics